Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Large Growth in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 6,541 shares, a growth of 495.7% from the August 15th total of 1,098 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily volume of 7,438 shares, the short-interest ratio is presently 0.9 days.

Fidelity Disruptive Medicine ETF Trading Up 0.5%

FMED stock traded up $0.16 on Friday, hitting $31.00. 4,171 shares of the company’s stock traded hands, compared to its average volume of 10,689. The stock has a market cap of $49.60 million, a price-to-earnings ratio of 41.33 and a beta of 0.77. Fidelity Disruptive Medicine ETF has a 1-year low of $23.48 and a 1-year high of $32.89. The stock has a fifty day moving average of $30.18 and a 200-day moving average of $27.04.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

Large investors have recently modified their holdings of the stock. Citadel Advisors LLC acquired a new stake in shares of Fidelity Disruptive Medicine ETF during the second quarter worth $282,000. Virtu Financial LLC acquired a new position in shares of Fidelity Disruptive Medicine ETF in the 4th quarter valued at $228,000. Jane Street Group LLC boosted its position in shares of Fidelity Disruptive Medicine ETF by 95.4% in the 4th quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after purchasing an additional 44,630 shares during the period. Finally, Vise Technologies Inc. purchased a new position in Fidelity Disruptive Medicine ETF in the 4th quarter worth about $234,000.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.